Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2280 |  ANRO Alto Neuroscience, Inc. Common Stock | 34.95 USD | +2.19% | +9.87% | +32.04% | +796.15% | 1.37 B USD | ||
| 2281 |  MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | 15.40 USD | -2.28% | -6.84% | -19.79% | +61.09% | 1.31 B USD | ||
| 2286 |  MNKD MannKind Corporation - Common Stock | 4.08 USD | -1.69% | +5.43% | -3.09% | -23.02% | 1.31 B USD | ||
| 2299 |  DRTS Alpha Tau Medical Ltd. - Ordinary Shares | 14.86 USD | -0.40% | +6.52% | +15.28% | +360.06% | 1.31 B USD | ||
| 2337 |  GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 13.56 USD | -5.17% | -12.46% | -41.95% | +20.00% | 1.16 B USD | ||
| 2340 |  CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 13.86 USD | -4.15% | -8.27% | +5.24% | +150.18% | 1.17 B USD | ||
| 2348 |  IMTX Immatics N.V. - Ordinary Shares | 8.69 USD | -2.69% | -7.06% | -5.44% | -16.04% | 1.17 B USD | ||
| 2368 |  SANA Sana Biotechnology, Inc. - Common Stock | 3.77 USD | -3.58% | +5.60% | +16.72% | +5.31% | 1.13 B USD | ||
| 2379 |  SVRA Savara, Inc. - Common Stock | 5.48 USD | -1.97% | +2.62% | -1.44% | +71.79% | 1.13 B USD | ||
| 2421 |  AVTX Avalo Therapeutics, Inc. - Common Stock | 19.15 USD | -3.43% | -2.59% | +3.51% | +97.42% | 1.03 B USD | ||
| 2422 |  JANX Janux Therapeutics, Inc. - Common Stock | 17.64 USD | +1.44% | +10.04% | +13.00% | -27.41% | 1.08 B USD | ||
| 2426 |  KURA Kura Oncology, Inc. - Common Stock | 11.84 USD | -0.42% | +7.54% | +10.04% | +53.97% | 1.05 B USD | ||
| 2434 |  WVE Wave Life Sciences Ltd. - Ordinary Shares | 5.19 USD | -1.89% | -2.99% | -12.33% | -27.51% | 1.02 B USD | ||
| 2439 |  ABUS Arbutus Biopharma Corporation - Common Stock | 5.21 USD | 0.00% | +11.09% | +18.14% | +45.53% | 1.03 B USD | ||
| 2444 |  LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 2.32 USD | +0.87% | -0.43% | +0.87% | +93.33% | 1.03 B USD | ||
| 2453 |  CADL Candel Therapeutics, Inc. - Common Stock | 12.46 USD | -5.10% | +7.51% | +28.85% | +109.41% | 953.42 M USD | ||
| 2459 |  SLDB Solid Biosciences Inc. - Common Stock | 8.96 USD | -3.66% | +0.22% | +11.86% | +57.19% | 960.74 M USD | ||
| 2463 |  CLYM Climb Bio, Inc. - Common Stock | 16.26 USD | -5.90% | -3.56% | +24.12% | +197.26% | 933.91 M USD | ||
| 2472 |  IMMX Immix Biopharma, Inc. - Common Stock | 13.20 USD | -3.37% | +21.32% | +52.95% | +513.95% | 944.32 M USD | ||
| 2473 |  GERN Geron Corporation - Common Stock | 1.48 USD | -2.63% | +1.37% | +2.07% | +1.37% | 950.86 M USD |
Noticias Biotechnology Stocks
Deutsche Bank rebaja argenx a Mantener por valoración
¿Por qué cae hoy la acción de Monte Rosa Therapeutics?
Las acciones de Biomea Fusion se disparan tras completar el ensayo sobre diabetes
Las acciones de Monte Rosa caen al inicio de un estudio de fase 2 contra el cáncer de próstata
Las acciones de Crinetics Pharmaceuticals alcanzan máximos históricos en 84,8 dólares
H.C. Wainwright reitera su calificación de Biomea Fusion tras inscripción en ensayo
La FDA amplía la revisión de deramiocel de Capricor hasta el 22 de noviembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |